Hearts Gainer
liked
As of March 24, 2025, the volatility of Tesla's (Tesla, NASDAQ: TSLA) stock price is influenced by multiple factors, including market sentiment, changes in the company's fundamentals, the macroeconomic environment, and the competitive landscape of the industry. While I am unable to provide real-time data, I can analyze key points that may drive volatility in Tesla's stock price based on known trends and potentially influential factors.
1. possib...
1. possib...
10
Hearts Gainer
liked
$GE Vernova (GEV.US)$ FYI
Jensen spoke yesterday that the constraint for data centers is power he went out of his way to say that that will determine the profitability of the data centers will they have the power that they demand.
GE vernova offers the fastest quickest way to power these data centers which is an on-site massive gas turbine their largest can power upwards of 300,000 households to give you an idea of the scale of energy it produces.
Natural gas is cheap gas is clean and these wo...
Jensen spoke yesterday that the constraint for data centers is power he went out of his way to say that that will determine the profitability of the data centers will they have the power that they demand.
GE vernova offers the fastest quickest way to power these data centers which is an on-site massive gas turbine their largest can power upwards of 300,000 households to give you an idea of the scale of energy it produces.
Natural gas is cheap gas is clean and these wo...
8
1
Hearts Gainer
liked
$Syros Pharmaceuticals (SYRS.US)$ has achieved several key milestones that may indicate potential for future growth despite current volatility:
1. Advancement of Tamibarotene: The company has been developing tamibarotene, an oral selective retinoic acid receptor alpha (RARα) agonist, targeting hematologic malignancies such as higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML) in patients with RARA gene overexpression.
2....
1. Advancement of Tamibarotene: The company has been developing tamibarotene, an oral selective retinoic acid receptor alpha (RARα) agonist, targeting hematologic malignancies such as higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML) in patients with RARA gene overexpression.
2....
6
Hearts Gainer
liked
Hearts Gainer
liked
Hearts Gainer
liked
2025 Mar 11 EST: Realized $NVIDIA (NVDA.US)$ shorts.
+USD $6314/day
Pre-market short gained +USD $3713; added more shorts at market hours to double the gain to +USD $6314
NVDA has became a very dangerous stock to hold.
#precisiontrading.
Control risk well today.
+USD $6314/day
Pre-market short gained +USD $3713; added more shorts at market hours to double the gain to +USD $6314
NVDA has became a very dangerous stock to hold.
#precisiontrading.
Control risk well today.

5